Quantitative assessment of anesthetic-induced cardiac sensitization to epinephrine.
D000769:Anesthesia, Inhalation; D000777:Anesthetics / Q000009:adverse effects*; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000138:chemical synthesis*; D001794:Blood Pressure / Q000187:drug effects; D002245:Carbon Dioxide / Q000097:blood; D002725:Chloroform / Q000009:adverse effects; D004285:Dogs; D004347:Drug Interactions; D004562:Electrocardiography; D004837:Epinephrine / Q000009:adverse effects*; D005019:Ethyl Ethers / Q000009:adverse effects; D005260:Female; D006221:Halothane / Q000009:adverse effects; D006846:Hydrocarbons, Halogenated; D006863:Hydrogen-Ion Concentration; D008297:Male; D008722:Methods; D008733:Methoxyflurane / Q000009:adverse effects; D010424:Pentobarbital; D011407:Propane; D013610:Tachycardia / Q000139:chemically induced; D014693:Ventricular Fibrillation / Q000139:chemically induced
D000777:Anesthetics; D005019:Ethyl Ethers; D006846:Hydrocarbons, Halogenated; D002245:Carbon Dioxide; D008733:Methoxyflurane; D002725:Chloroform; D010424:Pentobarbital; D011407:Propane; D006221:Halothane; D004837:Epinephrine